Company: ATRA
Filing Date: 2025-08-11
Form Type: 8-K
Source: 0000950170-25-106533
Chunk: 1

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-08-11
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                  
         99.1      Press Release, dated August 11, 2025                                         
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                           ATARA BIOTHERAPEUTICS, INC.                                                                        
  Date:      August 11, 2025      By:      /s/ Yanina Grant-Huerta                                                                            
                                           Yanina Grant-Huerta